Completed NA INTERVENTIONAL 3-arm NCT00215774

Flecainide-Short Long Study (Flec-SL)

Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.

Sponsor: Atrial Fibrillation Network

Interventions Flecainide

Updated 6 times since 2017 Last updated: Sep 10, 2012 Started: Mar 31, 2005 Primary completion: Oct 31, 2009 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00215774, this NA trial focuses on Atrial Fibrillation and remains completed. Sponsored by Atrial Fibrillation Network, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Completed NA

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atrial Fibrillation Network
German Federal Ministry of Education and Research
German Research Foundation
Meda Pharmaceuticals

Data source: Atrial Fibrillation Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.